HomeALT • NASDAQ
add
Altimmune Inc
Previous close
$3.54
Day range
$3.61 - $3.89
Year range
$2.90 - $7.73
Market cap
437.79M USD
Avg Volume
4.38M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 26.00K | 420.00% |
Operating expense | 10.51M | 106.48% |
Net income | -27.36M | -18.02% |
Net profit margin | -105.22K | 77.30% |
Earnings per share | -0.27 | 18.18% |
EBITDA | -28.87M | -16.24% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 273.46M | 107.33% |
Total assets | 279.93M | 100.95% |
Total liabilities | 55.04M | 248.38% |
Total equity | 224.89M | — |
Shares outstanding | 130.07M | — |
Price to book | 1.74 | — |
Return on assets | -28.99% | — |
Return on capital | -31.26% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -27.36M | -18.02% |
Cash from operations | -19.45M | -6.48% |
Cash from investing | -79.16M | -680.68% |
Cash from financing | 81.13M | 704.46% |
Net change in cash | -17.48M | -420.54% |
Free cash flow | -10.33M | -11.33% |
About
CEO
Founded
1997
Headquarters
Website
Employees
57
